Sustained Release Compositions for Undifferentiated Cell Culture

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for culturing undifferentiated mammalian cells, such as stem and progenitor cells, face challenges in maintaining cells in an undifferentiated state due to unstable growth factor levels, leading to spontaneous differentiation and increased labor and expense in frequent feeding requirements.

Innovation Solution

The use of a sustained release composition, like PLGA microspheres, to maintain a stable concentration of growth factors like FGF2 over an extended period, reducing the need for frequent feeding and minimizing spontaneous differentiation.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If growth factors are delivered daily or frequently to cell cultures, then the undifferentiated state is maintained better, but labor and expense increase significantly

Engineering Contradiction:
Improvemaintenance of undifferentiated stateVSAvoidlabor and expense for frequent feeding
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The patent incorporates growth factors into sustained-release compositions (such as hydrogels or microparticles) that are prepared in advance and added to cell cultures. These pre-prepared compositions release growth factors over extended periods (multiple days to weeks), eliminating the need for frequent manual feeding while maintaining reliable undifferentiated state

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The sustained-release compositions provide continuous release of growth factors at physiological concentrations over extended periods. This continuous delivery mechanism maintains stable growth factor levels in the culture medium, ensuring reliable maintenance of undifferentiated cells without interruption or fluctuation that would require frequent replenishment

Inventive Principle:
Principle #20Continuity of useful action

2Productivity

If growth factor levels are allowed to fluctuate, then labor is reduced, but spontaneous differentiation increases

Engineering Contradiction:
Improvereduction in feeding frequencyVSAvoidstability of undifferentiated state
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The sustained-release compositions are designed to release growth factors continuously at controlled rates over multiple days or weeks. This continuous release maintains stable, physiological concentrations of growth factors in the culture medium, preventing the fluctuations that would otherwise trigger spontaneous differentiation while allowing reduced feeding frequency

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent changes the temporal parameter of growth factor delivery from discrete, frequent additions to continuous, sustained release. By controlling the release kinetics of the composition, growth factor concentrations are maintained within optimal ranges for extended periods, ensuring stability of the undifferentiated state while reducing overall intervention frequency

Inventive Principle:
Principle #35Parameter changes

3Quantity of substance

If conventional feeding methods are used, then some undifferentiated cells are maintained, but culture homogeneity decreases due to spontaneous differentiation

Engineering Contradiction:
Improvenumber of undifferentiated cellsVSAvoidhomogeneity of cell culture
Core Design Contradiction:
Quantity of substanceVSStability of the object's composition

Solution Approach 1:

The sustained-release compositions provide uninterrupted, continuous delivery of growth factors at physiological concentrations. This continuous exposure prevents the periodic withdrawal and re-addition of growth factors that occurs with conventional feeding, thereby preventing spontaneous differentiation events and maintaining culture homogeneity while preserving the undifferentiated cell population

Inventive Principle:
Principle #20Continuity of useful action

Solution Approach 2:

The patent optimizes the release parameters of the sustained-release composition to match physiological growth factor levels. By controlling release rate, duration, and concentration to mimic natural conditions, the composition maintains all cells in the undifferentiated state uniformly, preventing the heterogeneous differentiation that occurs with conventional feeding methods

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach maintains cells in an undifferentiated state for longer periods with reduced labor and expense, improving the quality and homogeneity of cell cultures by maintaining stable growth factor levels.

Implementation Method 1

A sustained release composition that continuously releases the growth factor is used to maintain sustained levels of the growth factor

Methodology Applied
Scientific EffectSustained release:

Data Source

PatentEP4202040A1Methods for culturing undifferentiated cells using sustained release compositions
Publication Date: 2023.06.28 REGENERATIVE RES FOUND
  • EP4202040A1 patent drawingFigure 1A
  • EP4202040A1 patent drawingFigure 1B
  • EP4202040A1 patent drawingFigure 2

AI summary

Methods for culturing undifferentiated mammalian cells, such as stem and progenitor cells, are provided. The methods involve incubating the cell in the presence of a sustained release composition containing at least one growth factor, wherein the sustained release composition continuously releases the growth factor(s), and wherein the presence of the sustained level of growth factor maintains the cell in an undifferentiated state.